DOMPERIDONE AND LEVODOPA IN PARKINSONS-DISEASE

被引:43
作者
SHINDLER, JS
FINNERTY, GT
TOWLSON, K
DOLAN, AL
DAVIES, CL
PARKES, JD
机构
[1] INST PSYCHIAT,LONDON SE5 8AF,ENGLAND
[2] RADCLIFFE INFIRM,MRC,CLIN PHARMACOL RES UNIT,OXFORD OX2 6HE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1984.tb02571.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:959 / 962
页数:4
相关论文
共 16 条
[1]   METABOLISM AND ABSORPTION OF L-3,4 DIHYDROXYPHENYLALANINE IN PATIENTS WITH PARKINSONS DISEASE [J].
BIANCHINE, JR ;
CALIMLIM, LR ;
MORGAN, JP ;
DUJUVNE, CA ;
LASAGNA, L .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :126-+
[2]  
FERMAGLICH J, 1972, DIS NERV SYST, V33, P624
[3]   BRAIN-TISSUE AND PLASMA ASSAY OF L-DOPA AND ALPHA-METHYLDOPA METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
FREED, CR ;
ASMUS, PA .
JOURNAL OF NEUROCHEMISTRY, 1979, 32 (01) :163-168
[4]  
GUNDERTREMY U, 1983, EUR J CLIN PHARMACOL, V25, P69, DOI 10.1007/BF00544017
[5]   DOMPERIDONE, A SPECIFIC INVITRO DOPAMINE ANTAGONIST, DEVOID OF INVIVO CENTRAL DOPAMINERGIC ACTIVITY [J].
LADURON, PM ;
LEYSEN, JE .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (14) :2161-2165
[6]   ON-OFF EFFECTS IN PATIENTS WITH PARKINSONS-DISEASE ON CHRONIC LEVODOPA THERAPY [J].
MARSDEN, CD ;
PARKES, JD .
LANCET, 1976, 1 (7954) :292-296
[7]   METOCLOPRAMIDE, GASTRIC-EMPTYING AND L-DOPA ABSORPTION [J].
MEARRICK, PT ;
WADE, DN ;
BIRKETT, DJ ;
MORRIS, J .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1974, 4 (02) :144-148
[8]   IMIPRAMINE-MEDIATED INTERFERENCE WITH LEVODOPA ABSORPTION FROM GASTROINTESTINAL-TRACT IN MAN [J].
MORGAN, JP ;
RIVERACALIMLIM, L ;
MESSIHA, F ;
SUNDARESAN, PR ;
TRABERT, N .
NEUROLOGY, 1975, 25 (11) :1029-1034
[9]   THE ON OFF PHENOMENON IN PARKINSONS-DISEASE - RELATION TO LEVODOPA ABSORPTION AND TRANSPORT [J].
NUTT, JG ;
WOODWARD, WR ;
HAMMERSTAD, JP ;
CARTER, JH ;
ANDERSON, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (08) :483-488
[10]   ADVERSE-EFFECTS OF ANTI-PARKINSONIAN DRUGS [J].
PARKES, JD .
DRUGS, 1981, 21 (05) :341-353